HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

scillarenin

structure given in Merck

Also Known As:

3,14-dihydroxybufa-4,20,22-trienolide

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Fused-Ring Compounds
  - Steroids: 70059
    - Cardanolides
      - Cardiac Glycosides: 1002
        Bufanolides: 91
        scillarenin: 1

Experts

1.	Bauer, Rudolf: 1 article (07/2010)
2.	Boechzelt, Herbert: 1 article (07/2010)
3.	Efferth, Thomas: 1 article (07/2010)
4.	Fricker, Gert: 1 article (07/2010)
5.	Hao, Xiaojiang: 1 article (07/2010)
6.	Kahl, Stefan: 1 article (07/2010)
7.	Karamustafa, Shirin: 1 article (07/2010)
8.	Klotz, Daniel: 1 article (07/2010)
9.	Konkimalla, V Badireenath: 1 article (07/2010)
10.	Liu, Hai-Yang: 1 article (07/2010)

Related Diseases

1.	Brain Diseases (Brain Disorder) 07/01/2010 - "Taken together, these data show that scillarenin is a potential novel candidate for P-glycoprotein inhibition at BBB, and, thereby, may improve the efficacy of therapy regimens in treating brain diseases."

Related Drugs and Biologics

1.	Member 1 Subfamily B ATP Binding Cassette Transporter

Related Therapies and Procedures

1.	Therapeutics